
The Innovative Medicines Initiative (IMI) organically grew into a powerhouse of international alliances. The new partnership’s multi-sectoral nature means that the catchment will...
The Innovative Medicines Initiative (IMI) organically grew into a powerhouse of international alliances. The new partnership’s multi-sectoral nature means that the catchment will...
IMI-funded IMSAVAR reviewed the state of ‘cancer-on-chip’ technology. While promising, problems with manufacturing to scale make them impractical for the moment.
The Children’s Tumor Foundation and the Global Coalition for Adaptive Research are making EU-PEARL’s model for a platform trial for patients with neurofibromatosis-1 (NF-1) and...
IHI took part in the European Cancer Meeting 2022 of the French National Cancer Institute which was held in Paris, France, on 3 to 4 February 2022. It took place at the French, Economic, Social and...
The document details the areas IHI should work on and guides IHI’s decisions on call topics.
Researchers from COMBACTE-CDI filled important knowledge gaps on the scale of C. diff infections, and sequenced the genomes of hundreds of strains for future researchers
Online tool allows scientists to monitor the numbers of people looking up respiratory syncytial virus (RSV) online – a useful indication of disease activity.
Up until fairly recently, women were largely left out of clinical trials and there are still gaps in what we know about women’s health. IHI and IMI projects are investigating safe...